3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
19
Terminated
5
Recruiting
3
Active not recruiting
3
Withdrawn
2
Not yet recruiting
2
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Leukemia
15
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Lymphoma, Non-Hodgkin
8
Lymphoma
8
Leukemia, Myeloid, Acute
8
Multiple Myeloma
6
Myelodysplastic Syndromes
5
Lymphoma, Large B-Cell, Diffuse
5
Leukemia, Myeloid, Chronic-Phase
5
Neuroblastoma
4
Hodgkin Disease
4
Graft vs Host Disease
4
Congenital Abnormalities
4
Recurrence
3
Neoplasms, Plasma Cell
3
Lymphoma, Mantle-Cell
3
Lymphoma, Large-Cell, Immunoblastic
3
Lymphoma, Follicular
3
Leukemia, Myelomonocytic, Juvenile
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Burkitt Lymphoma
3
Sarcoma
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Lymphoma, Large-Cell, Anaplastic
2
Lymphoma, Extranodal NK-T-Cell
2
Lymphoma, B-Cell, Marginal Zone
2
Leukemia, Myelomonocytic, Acute
2
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
2
Leukemia, Myeloid, Accelerated Phase
2
Interventions
Cyclophosphamide
6
fludarabine
5
Exercise
4
Blood Specimen Collection
4
Surveys and Questionnaires
3
Immunotherapy, Adoptive
3
thymoglobulin
2
pegylated granulocyte colony-stimulating factor
2
Voriconazole
2
Stem Cell Transplantation
2
Saline Solution
2
Physical Therapy Modalities
2
Parenteral Nutrition
2
Mycophenolic Acid
2
Etoposide
2
Cytarabine
2
CF regimen
2
BNT162 Vaccine
2
Azacitidine
2
venetoclax
1
trihexyltetradecylphosphonium chloride
1
treosulfan
1
shengxuening
1
ruxolitinib
1
ramosetron
1
monalizumab
1
glucarpidase
1
fludarabine phosphate
1
ferrous succinate
1
eltrombopag
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Hematologic Neoplasms
×
Busulfan
×
Clear all
NCT00750126
2011-01-19
RICE
University Hospital, Clermont-Ferrand
Phase 2
Unknown
30 enrolled